Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2010 1
2013 1
2014 3
2015 1
2016 2
2017 1
2018 1
2020 2
2024 2
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Lymphoma accelerates T cell and tissue aging.
Hesterberg RS, Davis JT, Handoo KJ, Elmarsafawi AG, Augello AC, Cheng CH, Atkins R, Lee DH, Yang C, Yao J, Patel KR, Mediavilla-Varela M, Pinilla-Ibarz J, Soto-Palma C, Locke FL, Song X, Wang X, Berglund AE, Rodriguez PC, Knittel G, Flümann R, Reinhardt HC, Shaw TI, Yu X, Niedernhofer LJ, Cleveland JL. Hesterberg RS, et al. Among authors: mediavilla varela m. Cancer Cell. 2025 Oct 13;43(10):1917-1936.e8. doi: 10.1016/j.ccell.2025.07.023. Epub 2025 Aug 21. Cancer Cell. 2025. PMID: 40845845 Free PMC article.
Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL.
Uriepero-Palma A, Márquez ME, Payque E, Mediavilla-Varela M, Gamal W, Maharaj K, Powers J, Chavez J, Eksioglu E, Sernbo S, Palacios F, Querol-Rivas J, Ortega C, Uria R, Santos GD, Oliver C, Landoni AI, Sahakian E, Oppezzo P, Pinilla-Ibarz J. Uriepero-Palma A, et al. Among authors: mediavilla varela m. Blood Adv. 2025 Oct 28;9(20):5219-5233. doi: 10.1182/bloodadvances.2025016061. Blood Adv. 2025. PMID: 40720748 Free PMC article. Review.
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.
Gamal W, Goedhart NB, Simon-Molas H, Mediavilla-Varela M, Uriepero-Palma A, Peters FS, Maharaj K, Chavez JC, Powers J, Obermayer A, Shaw TI, Conejo-Garcia JR, Rodriguez PC, Sahakian E, Pinilla-Ibarz J, Kater AP. Gamal W, et al. Among authors: mediavilla varela m. Blood Adv. 2025 May 27;9(10):2511-2529. doi: 10.1182/bloodadvances.2024014822. Blood Adv. 2025. PMID: 39938006 Free PMC article.
Indoleamine 2,3-dioxygenase: is it an immune suppressor?
Soliman H, Mediavilla-Varela M, Antonia S. Soliman H, et al. Among authors: mediavilla varela m. Cancer J. 2010 Jul-Aug;16(4):354-9. doi: 10.1097/PPO.0b013e3181eb3343. Cancer J. 2010. PMID: 20693847 Free PMC article. Review.
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
Maharaj K, Powers JJ, Achille A, Mediavilla-Varela M, Gamal W, Burger KL, Fonseca R, Jiang K, Miskin HP, Maryanski D, Monastyrskyi A, Duckett DR, Roush WR, Cleveland JL, Sahakian E, Pinilla-Ibarz J. Maharaj K, et al. Among authors: mediavilla varela m. Blood Adv. 2020 Jul 14;4(13):3072-3084. doi: 10.1182/bloodadvances.2020001800. Blood Adv. 2020. PMID: 32634240 Free PMC article.
23 results